Duopharma Biotech Bhd (7148) — Net Asset Quality Index
Duopharma Biotech Bhd (7148) has a Net Asset Quality Index of 52.4% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of RM1.45 Billion minus total liabilities of RM689.10 Million yields net assets of RM757.35 Million. A higher index indicates a stronger, lower-leverage balance sheet. See 7148 defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Quality Index
Net Assets
Total Assets
Total Liabilities
Duopharma Biotech Bhd Net Asset Quality Index Over Time (2006–2025)
This chart shows how Duopharma Biotech Bhd's Net Asset Quality Index has evolved across 20 annual periods from 2006 to 2025. As of March 2026, the index stands at 52.4%, representing net assets of RM757.35 Million against total assets of RM1.45 Billion MYR. Explore Duopharma Biotech Bhd cash flow conversion to assess how effectively this company generates cash.
Annual Net Asset Quality Index for Duopharma Biotech Bhd (2006–2025)
The table below presents the year-by-year Net Asset Quality Index for Duopharma Biotech Bhd from 2006 to 2025, covering 20 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see Duopharma Biotech Bhd (7148) market capitalisation.
| Year | Quality Index | Net Assets (MYR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 52.3% | RM757.62 Million | RM1.45 Billion | RM690.68 Million | ▲ +0.8 pp |
| 2024 | 51.5% | RM709.15 Million | RM1.38 Billion | RM667.85 Million | ▲ +0.4 pp |
| 2023 | 51.1% | RM687.12 Million | RM1.35 Billion | RM658.01 Million | ▼ -2.5 pp |
| 2022 | 53.6% | RM655.22 Million | RM1.22 Billion | RM566.70 Million | ▲ +0.0 pp |
| 2021 | 53.6% | RM624.00 Million | RM1.16 Billion | RM540.13 Million | ▼ -7.2 pp |
| 2020 | 60.8% | RM643.82 Million | RM1.06 Billion | RM414.61 Million | ▲ +3.2 pp |
| 2019 | 57.6% | RM529.75 Million | RM919.80 Million | RM390.05 Million | ▲ +0.1 pp |
| 2018 | 57.5% | RM481.04 Million | RM836.38 Million | RM355.34 Million | ▼ -10.5 pp |
| 2017 | 68.0% | RM479.87 Million | RM705.24 Million | RM225.38 Million | ▼ -0.7 pp |
| 2016 | 68.7% | RM454.52 Million | RM661.46 Million | RM206.95 Million | ▼ -2.3 pp |
| 2015 | 71.0% | RM449.72 Million | RM633.45 Million | RM183.73 Million | ▼ -16.0 pp |
| 2014 | 87.0% | RM193.63 Million | RM222.48 Million | RM28.85 Million | ▼ -1.8 pp |
| 2013 | 88.8% | RM182.65 Million | RM205.65 Million | RM23.00 Million | ▲ +2.7 pp |
| 2012 | 86.1% | RM170.50 Million | RM198.03 Million | RM27.53 Million | ▲ +2.8 pp |
| 2011 | 83.3% | RM164.44 Million | RM197.52 Million | RM33.08 Million | ▲ +2.9 pp |
| 2010 | 80.3% | RM157.87 Million | RM196.48 Million | RM38.61 Million | ▼ -2.0 pp |
| 2009 | 82.3% | RM142.74 Million | RM173.36 Million | RM30.63 Million | ▼ -4.5 pp |
| 2008 | 86.8% | RM130.55 Million | RM150.38 Million | RM19.83 Million | ▼ -2.9 pp |
| 2007 | 89.7% | RM114.21 Million | RM127.33 Million | RM13.12 Million | ▼ -1.8 pp |
| 2006 | 91.5% | RM145.43 Million | RM159.01 Million | RM13.58 Million | — |